Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 309 followers

Latest posts

Last updated 2 days ago

Validation checklist for Type II (non) clinical variations

2 days ago

Validation checklist for Type II (non) clinical variations

Obtaining and maintaining a scientific opinion on a medicine for use outside the European Union

3 days ago

Obtaining and maintaining a scientific opinion on a medicine for use outside...

PSUSA/00010396/202504

3 days ago

PSUSA/00010396/202504

PSUSA/00000583/202503

3 days ago

PSUSA/00000583/202503

Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures Under evaluation, 30/01/2026

3 days ago

Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures Under evaluation, 30/01/2026

Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Date of authorisation: 05/03/2002, Revision: 33, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Date of...

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 27, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation...

Use of Bayesian methods in clinical development - Scientific guideline

3 days ago

Use of Bayesian methods in clinical development - Scientific guideline

Concept paper for the development of a reflection paper on the use of Bayesian methods in clinical development

3 days ago

Concept paper for the development of a reflection paper on the use...

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 27, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation...